The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Carella Thomas J. since 2010.
The trader's CIK number is 1477767.
At the time of the last reporting, Carella Thomas J. was the Director of T2 Biosystems, Inc.. (stock ticker symbol TTOO).
Also see all insider trading activities at T2 Biosystems, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | TTOO | 700,000 | $6,825,000 | 0 | $0 | 0 | $0 |
| 2014 | TTOO | 909,090 | $9,999,990 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | KAR | 0 | $0 | 23,147,052 | $551,726,200 | 0 | $0 |
| 2012 | KAR | 0 | $0 | 3,934,778 | $65,758,009 | 0 | $0 |
| 2010 | KAR | 100 | $1,500 | 100 | $1,500 | 0 | $0 |
2. Kar Auction Services, Inc. (KAR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-01 | TTOO | Buy | 700,000 | 9.75 | 6,825,000 |
| 2014-08-01 | TTOO | Buy | 909,090 | 11.00 | 9,999,990 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-11-01 | KAR | Sale | 7,116,476 | 27.14 | 193,141,158 |
| 2013-09-01 | KAR | Sale | 3,497,581 | 26.62 | 93,123,094 |
| 2013-08-01 | KAR | Sale | 4,371,975 | 24.25 | 106,020,393 |
| 2013-06-01 | KAR | Sale | 4,371,975 | 20.45 | 89,420,004 |
| 2013-03-01 | KAR | Sale | 3,789,045 | 18.48 | 70,021,551 |
| 2012-12-01 | KAR | Sale | 3,934,778 | 16.71 | 65,758,009 |
| 2010-05-10 | KAR | Buy | 100 | 15.00 | 1,500 |
| 2010-05-10 | KAR | Sale | 100 | 15.00 | 1,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carella Thomas J. (Director of T2 Biosystems, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.